sleep apnea and glp 1 The pleiotropic effects of glucagon-like peptide-1 receptor agonists 🗞️ GLP-1s are making headlines,

Novo Nordisk reined in its growth forecasts for the year in its second-quarter financial results update, blaming "persistent use of compounded GLP-1s, slower-than-expected market expansion, and competition." Compounding of semaglutide should have come to a halt in the US since the drug was removed from the FDA list of medicines in short supply, but various companies continue to provide compounded GLP-1s under a loophole that allows the sale of 'personalised' formulations

Mitochondrial dysfunction in Parkinsons disease: a possible target for neuroprotection

Biomolecules, 11 (10), 1441

Image Credit: Gecko Studio / Shutterstock In a recent review published in The Lancet , researchers synthesized decades of research on incretin-based medications

Amino acid derivatives and reagents for peptide synthesis were purchased from Watanabe Chemical (Hiroshima, Japan)

Its the safest and most effective way to explore the benefits of regenerative medicine